Berliner Boersenzeitung - US court keeps abortion drug available -- for now

EUR -
AED 4.31106
AFN 77.698272
ALL 96.82246
AMD 448.150206
ANG 2.1013
AOA 1076.442782
ARS 1688.640476
AUD 1.763687
AWG 2.115909
AZN 1.995058
BAM 1.958285
BBD 2.364891
BDT 143.492098
BGN 1.957669
BHD 0.442466
BIF 3470.489427
BMD 1.173875
BND 1.516418
BOB 8.113262
BRL 6.32906
BSD 1.174185
BTN 106.185302
BWP 15.557677
BYN 3.461478
BYR 23007.944129
BZD 2.361487
CAD 1.615739
CDF 2623.609572
CHF 0.932995
CLF 0.027346
CLP 1072.806755
CNY 8.285266
CNH 8.277307
COP 4450.147251
CRC 587.342863
CUC 1.173875
CUP 31.10768
CVE 110.404638
CZK 24.250079
DJF 209.09446
DKK 7.469346
DOP 74.644409
DZD 152.375977
EGP 55.806239
ERN 17.608121
ETB 183.464844
FJD 2.666809
FKP 0.874332
GBP 0.877865
GEL 3.16976
GGP 0.874332
GHS 13.479048
GIP 0.874332
GMD 85.692405
GNF 10211.91589
GTQ 8.993413
GYD 245.650696
HKD 9.138585
HNL 30.913098
HRK 7.532516
HTG 153.904656
HUF 384.689892
IDR 19546.715881
ILS 3.772041
IMP 0.874332
INR 106.305565
IQD 1538.145425
IRR 49431.863924
ISK 148.389096
JEP 0.874332
JMD 187.998579
JOD 0.832252
JPY 183.02643
KES 151.406062
KGS 102.654945
KHR 4700.945691
KMF 493.027258
KPW 1056.482805
KRW 1734.388286
KWD 0.360039
KYD 0.978538
KZT 612.374523
LAK 25455.195379
LBP 105147.188709
LKR 362.818888
LRD 207.242117
LSL 19.81004
LTL 3.466147
LVL 0.710065
LYD 6.378067
MAD 10.802263
MDL 19.849105
MGA 5201.578885
MKD 61.536375
MMK 2465.451687
MNT 4164.175659
MOP 9.415408
MRU 46.990433
MUR 53.904653
MVR 18.089902
MWK 2036.0752
MXN 21.181313
MYR 4.813472
MZN 75.004372
NAD 19.81004
NGN 1705.076549
NIO 43.214842
NOK 11.891009
NPR 169.896883
NZD 2.021876
OMR 0.451351
PAB 1.174185
PEN 3.953217
PGK 5.061402
PHP 69.284437
PKR 329.061893
PLN 4.223143
PYG 7887.008974
QAR 4.279312
RON 5.089891
RSD 117.372183
RUB 93.51582
RWF 1708.961471
SAR 4.4047
SBD 9.661684
SCR 15.992527
SDG 706.081156
SEK 10.883433
SGD 1.515519
SHP 0.88071
SLE 28.290721
SLL 24615.563347
SOS 669.847213
SRD 45.250539
STD 24296.836256
STN 24.531027
SVC 10.273994
SYP 12981.15335
SZL 19.803047
THB 37.001682
TJS 10.790648
TMT 4.108561
TND 3.432556
TOP 2.826409
TRY 50.118514
TTD 7.968078
TWD 36.663978
TZS 2899.470481
UAH 49.612049
UGX 4173.296103
USD 1.173875
UYU 46.078279
UZS 14145.891528
VES 310.76556
VND 30879.947871
VUV 142.609534
WST 3.268004
XAF 656.787696
XAG 0.018276
XAU 0.00027
XCD 3.172456
XCG 2.116177
XDR 0.81606
XOF 656.787696
XPF 119.331742
YER 279.822366
ZAR 19.780377
ZMK 10566.277856
ZMW 27.094268
ZWL 377.987175
  • CMSC

    -0.0460

    23.384

    -0.2%

  • SCS

    0.0200

    16.14

    +0.12%

  • BCC

    0.5500

    76.81

    +0.72%

  • RIO

    -1.6500

    75.09

    -2.2%

  • GSK

    -0.2800

    48.6

    -0.58%

  • JRI

    -0.0600

    13.66

    -0.44%

  • NGG

    0.0500

    74.74

    +0.07%

  • BTI

    -1.8060

    56.564

    -3.19%

  • AZN

    -0.7800

    89.51

    -0.87%

  • RYCEF

    -0.1000

    14.64

    -0.68%

  • RBGPF

    0.0000

    81.17

    0%

  • BP

    -0.1300

    35.4

    -0.37%

  • RELX

    0.0200

    40.3

    +0.05%

  • BCE

    0.3900

    23.79

    +1.64%

  • VOD

    0.0350

    12.575

    +0.28%

  • CMSD

    -0.1050

    23.295

    -0.45%

US court keeps abortion drug available -- for now
US court keeps abortion drug available -- for now / Photo: Robyn Beck - AFP/File

US court keeps abortion drug available -- for now

A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.

Text size:

The ruling issued late Wednesday preserves access for now to mifepristone -- used for more than half of all abortions in the United States -- but a question mark remains over its long-term availability in a case likely to go all the way to Supreme Court.

The new order limits access to women in the first seven weeks of pregnancy, down from 10; it requires in-person visits to obtain the pill -- a requirement lifted in recent years; and it blocks the medication from being sent by mail.

Wednesday's 2-1 ruling by a federal appeals court in New Orleans, Louisiana, came after a Texas judge overturned the Food and Drug Administration's (FDA) two-decades old approval of the drug last Friday.

The appellate court said its ruling would hold until the case was heard in full -- likely by the Supreme Court.

The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.

- 'Commitment to women' -

US President Joe Biden has branded the Texas ruling as "out of bounds," and his spokeswoman, Karine Jean-Pierre, said Thursday the administration would continue fighting it in court.

"We believe that the law is on our side, and we will prevail," she told reporters during the president's visit to Dublin, Ireland.

"I can reassure the American people that that is our commitment to women ... to make sure that women are able to make decisions for themselves about their own body," she added.

Democrats and activists warn the Texas ruling -- issued by a judge appointed by former Republican president Donald Trump -- moves the nation one step closer to a nationwide abortion ban sought by many conservatives.

Judge Matthew Kacsmaryk's ruling came after a coalition of anti-abortion groups sued to freeze the national distribution of mifepristone.

The Texas judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."

Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.

But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.

Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.

The two New Orleans judges who voted to tighten restrictions on access, Kurt Engelhardt and Andrew Oldham, were also both appointed by Trump.

The third, Catharina Haynes, is an appointee of former president George W. Bush.

Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved. The dueling opinions, along with the appeals, mean the issue is almost certain to end up before the Supreme Court.

(T.Renner--BBZ)